Leronlimab

Tax included
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody. Leronlimab inhibits CCR5-mediated HIV-1 viral and lung metastasis in mouse tumor models. Leronlimab can be used for the research of HIV nonalcoholic steatohepatitis (NASH) and cancer.
MedChemExpress 
HY-P99697

Data sheet

Size
Multiple sizes
Reactivity
CCR; HIV
Application
COVID-19-anti-virus
CAS
674782-26-4